Jonathan Harris
Concepts (372)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 21 | 2023 | 730 | 4.320 |
Why?
| | Cystic Fibrosis | 22 | 2023 | 1163 | 3.730 |
Why?
| | Bacteria | 24 | 2023 | 766 | 2.270 |
Why?
| | Respiratory System Agents | 2 | 2022 | 22 | 1.310 |
Why?
| | DNA, Bacterial | 11 | 2021 | 320 | 1.290 |
Why?
| | RNA, Ribosomal, 16S | 20 | 2023 | 508 | 1.280 |
Why?
| | Pseudomonas Infections | 6 | 2023 | 231 | 1.250 |
Why?
| | Bronchoalveolar Lavage Fluid | 9 | 2022 | 638 | 1.190 |
Why?
| | Aminophenols | 2 | 2022 | 203 | 1.100 |
Why?
| | Sputum | 7 | 2020 | 302 | 1.020 |
Why?
| | Metagenome | 8 | 2014 | 126 | 1.020 |
Why?
| | Lung | 12 | 2022 | 4116 | 0.920 |
Why?
| | Eosinophilic Esophagitis | 2 | 2022 | 332 | 0.870 |
Why?
| | Sequence Analysis, DNA | 20 | 2015 | 778 | 0.850 |
Why?
| | Oropharynx | 3 | 2015 | 46 | 0.840 |
Why?
| | RNA, Bacterial | 9 | 2015 | 182 | 0.750 |
Why?
| | Respiratory Tract Infections | 5 | 2023 | 396 | 0.730 |
Why?
| | Intestines | 3 | 2014 | 354 | 0.690 |
Why?
| | Pseudomonas aeruginosa | 6 | 2023 | 397 | 0.680 |
Why?
| | Water Microbiology | 9 | 2018 | 85 | 0.670 |
Why?
| | Inflammation | 10 | 2022 | 2885 | 0.670 |
Why?
| | Quinolones | 2 | 2022 | 204 | 0.660 |
Why?
| | Phylogeny | 19 | 2016 | 917 | 0.630 |
Why?
| | Respiratory System | 3 | 2016 | 150 | 0.610 |
Why?
| | Biofilms | 6 | 2020 | 292 | 0.580 |
Why?
| | Polymerase Chain Reaction | 11 | 2015 | 1043 | 0.560 |
Why?
| | Anti-Bacterial Agents | 9 | 2023 | 1925 | 0.550 |
Why?
| | Trachea | 6 | 2023 | 258 | 0.510 |
Why?
| | Parenteral Nutrition | 2 | 2014 | 102 | 0.480 |
Why?
| | Alphaproteobacteria | 2 | 2016 | 7 | 0.460 |
Why?
| | Bronchiectasis | 2 | 2017 | 115 | 0.460 |
Why?
| | Child | 22 | 2023 | 22740 | 0.450 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 4 | 2022 | 373 | 0.440 |
Why?
| | Bronchi | 1 | 2016 | 263 | 0.430 |
Why?
| | Metagenomics | 3 | 2022 | 150 | 0.420 |
Why?
| | Bacteria, Anaerobic | 2 | 2011 | 25 | 0.420 |
Why?
| | Deoxyribonuclease I | 1 | 2013 | 41 | 0.390 |
Why?
| | Saliva | 1 | 2015 | 249 | 0.380 |
Why?
| | Staphylococcus aureus | 2 | 2021 | 454 | 0.380 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 237 | 0.370 |
Why?
| | Seawater | 1 | 2012 | 33 | 0.360 |
Why?
| | Chemoradiotherapy | 1 | 2013 | 239 | 0.350 |
Why?
| | Geologic Sediments | 4 | 2008 | 46 | 0.350 |
Why?
| | Biodiversity | 8 | 2014 | 311 | 0.340 |
Why?
| | Humans | 47 | 2023 | 145785 | 0.340 |
Why?
| | Molecular Sequence Data | 17 | 2015 | 2883 | 0.340 |
Why?
| | Sequence Analysis | 1 | 2011 | 34 | 0.340 |
Why?
| | Eczema | 1 | 2012 | 66 | 0.340 |
Why?
| | Oxygen | 3 | 2020 | 981 | 0.330 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 227 | 0.320 |
Why?
| | Age Factors | 1 | 2017 | 3346 | 0.310 |
Why?
| | Gene Library | 1 | 2010 | 122 | 0.300 |
Why?
| | Staining and Labeling | 1 | 2010 | 153 | 0.300 |
Why?
| | Proteomics | 4 | 2022 | 1188 | 0.300 |
Why?
| | Environmental Microbiology | 3 | 2005 | 47 | 0.290 |
Why?
| | Luminescent Measurements | 1 | 2019 | 75 | 0.290 |
Why?
| | Bacteriological Techniques | 1 | 2019 | 66 | 0.290 |
Why?
| | Hypersensitivity | 1 | 2012 | 254 | 0.280 |
Why?
| | Adolescent | 14 | 2021 | 22577 | 0.280 |
Why?
| | Liver | 2 | 2014 | 1899 | 0.280 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 641 | 0.270 |
Why?
| | Head and Neck Neoplasms | 1 | 2013 | 561 | 0.270 |
Why?
| | Models, Statistical | 2 | 2016 | 672 | 0.270 |
Why?
| | Male | 26 | 2021 | 73012 | 0.270 |
Why?
| | Cytokines | 2 | 2015 | 2069 | 0.260 |
Why?
| | Genes, rRNA | 6 | 2012 | 38 | 0.260 |
Why?
| | Legionella | 3 | 2017 | 9 | 0.260 |
Why?
| | Tobramycin | 3 | 2023 | 63 | 0.250 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 920 | 0.250 |
Why?
| | Lung Diseases | 2 | 2018 | 782 | 0.250 |
Why?
| | Prospective Studies | 8 | 2023 | 8078 | 0.240 |
Why?
| | Water Pollutants, Chemical | 2 | 2020 | 227 | 0.240 |
Why?
| | Female | 25 | 2021 | 79045 | 0.240 |
Why?
| | Drinking Water | 3 | 2017 | 90 | 0.230 |
Why?
| | Endoribonucleases | 3 | 2001 | 77 | 0.220 |
Why?
| | RNA, Archaeal | 3 | 2008 | 12 | 0.220 |
Why?
| | RNA, Catalytic | 3 | 2001 | 191 | 0.220 |
Why?
| | Drug Resistance | 2 | 2017 | 145 | 0.220 |
Why?
| | Construction Materials | 2 | 2015 | 18 | 0.210 |
Why?
| | Critical Illness | 3 | 2023 | 900 | 0.210 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2021 | 337 | 0.210 |
Why?
| | Evolution, Molecular | 3 | 2005 | 494 | 0.210 |
Why?
| | Air Microbiology | 2 | 2015 | 37 | 0.210 |
Why?
| | Azithromycin | 2 | 2023 | 101 | 0.210 |
Why?
| | Infant | 7 | 2023 | 10091 | 0.200 |
Why?
| | Staphylococcus | 5 | 2017 | 74 | 0.200 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2015 | 534 | 0.200 |
Why?
| | Biota | 2 | 2015 | 29 | 0.190 |
Why?
| | Kupffer Cells | 2 | 2014 | 52 | 0.190 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 260 | 0.190 |
Why?
| | Genes | 1 | 2003 | 228 | 0.190 |
Why?
| | Premature Birth | 3 | 2017 | 390 | 0.180 |
Why?
| | Young Adult | 8 | 2021 | 14254 | 0.180 |
Why?
| | Smoke | 2 | 2023 | 148 | 0.180 |
Why?
| | Calreticulin | 1 | 2022 | 22 | 0.180 |
Why?
| | Adrenal Cortex Hormones | 2 | 2017 | 484 | 0.180 |
Why?
| | HMGB Proteins | 1 | 2022 | 15 | 0.180 |
Why?
| | Soil Microbiology | 2 | 2015 | 115 | 0.180 |
Why?
| | Administration, Inhalation | 1 | 2023 | 571 | 0.180 |
Why?
| | Archaea | 4 | 2010 | 61 | 0.180 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 41 | 0.180 |
Why?
| | Respiration, Artificial | 4 | 2023 | 714 | 0.180 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2022 | 90 | 0.180 |
Why?
| | Adult | 11 | 2022 | 40882 | 0.180 |
Why?
| | Infant, Newborn | 5 | 2023 | 6465 | 0.170 |
Why?
| | Genes, Bacterial | 4 | 2012 | 152 | 0.170 |
Why?
| | Gastritis | 1 | 2022 | 117 | 0.170 |
Why?
| | Mexico | 6 | 2012 | 233 | 0.170 |
Why?
| | Enteritis | 1 | 2022 | 105 | 0.170 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2022 | 81 | 0.160 |
Why?
| | Pneumonia, Bacterial | 2 | 2014 | 113 | 0.160 |
Why?
| | Leptin | 1 | 2022 | 248 | 0.160 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2021 | 58 | 0.160 |
Why?
| | Groundwater | 1 | 2020 | 40 | 0.160 |
Why?
| | Eosinophilia | 1 | 2022 | 224 | 0.160 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 317 | 0.150 |
Why?
| | Sweat | 1 | 2020 | 51 | 0.150 |
Why?
| | Mutation | 2 | 2022 | 4090 | 0.150 |
Why?
| | Dysbiosis | 1 | 2021 | 188 | 0.150 |
Why?
| | Proteome | 2 | 2022 | 513 | 0.150 |
Why?
| | Ecosystem | 3 | 2010 | 478 | 0.140 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2017 | 420 | 0.140 |
Why?
| | Escherichia coli Proteins | 1 | 2001 | 201 | 0.140 |
Why?
| | Forced Expiratory Volume | 1 | 2020 | 450 | 0.140 |
Why?
| | Corrosion | 2 | 2015 | 16 | 0.140 |
Why?
| | Hydraulic Fracking | 1 | 2018 | 16 | 0.140 |
Why?
| | Chloramines | 2 | 2015 | 14 | 0.140 |
Why?
| | Aptamers, Nucleotide | 1 | 2019 | 87 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2019 | 3634 | 0.130 |
Why?
| | Intubation, Intratracheal | 2 | 2017 | 327 | 0.130 |
Why?
| | Dacryocystorhinostomy | 1 | 2017 | 13 | 0.130 |
Why?
| | Lipids | 1 | 2022 | 707 | 0.130 |
Why?
| | Nucleic Acid Conformation | 5 | 2005 | 724 | 0.120 |
Why?
| | DNA, Ribosomal | 5 | 2015 | 84 | 0.120 |
Why?
| | Fusobacterium | 1 | 2016 | 2 | 0.120 |
Why?
| | Eukaryotic Cells | 2 | 2007 | 35 | 0.120 |
Why?
| | Fusobacterium Infections | 1 | 2016 | 7 | 0.120 |
Why?
| | Haemophilus | 1 | 2016 | 8 | 0.120 |
Why?
| | Proton Pump Inhibitors | 1 | 2017 | 109 | 0.120 |
Why?
| | Rivers | 1 | 2016 | 62 | 0.120 |
Why?
| | Haemophilus Infections | 1 | 2016 | 46 | 0.110 |
Why?
| | Ribonuclease P | 4 | 2005 | 22 | 0.110 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.110 |
Why?
| | Esophagitis | 1 | 2016 | 67 | 0.110 |
Why?
| | Biomarkers | 4 | 2020 | 4302 | 0.110 |
Why?
| | Sanitary Engineering | 1 | 2015 | 5 | 0.110 |
Why?
| | Regression Analysis | 1 | 2017 | 1001 | 0.110 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.110 |
Why?
| | Pseudomonas | 1 | 2015 | 30 | 0.110 |
Why?
| | Health Facilities | 1 | 2015 | 85 | 0.110 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2968 | 0.110 |
Why?
| | Child, Preschool | 5 | 2021 | 11868 | 0.110 |
Why?
| | Enterobacteriaceae | 1 | 2015 | 44 | 0.110 |
Why?
| | Household Articles | 1 | 2014 | 28 | 0.110 |
Why?
| | Humidity | 1 | 2014 | 49 | 0.110 |
Why?
| | Plant Oils | 1 | 2014 | 33 | 0.110 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 42 | 0.110 |
Why?
| | Bronchoalveolar Lavage | 1 | 2014 | 89 | 0.110 |
Why?
| | Middle Aged | 6 | 2017 | 36309 | 0.110 |
Why?
| | Disease Progression | 3 | 2017 | 2865 | 0.110 |
Why?
| | Spirometry | 1 | 2015 | 233 | 0.100 |
Why?
| | Bacterial Proteins | 2 | 2016 | 968 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1547 | 0.100 |
Why?
| | Cyanobacteria | 2 | 2012 | 51 | 0.100 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 47 | 0.100 |
Why?
| | Neutrophils | 2 | 2021 | 1127 | 0.100 |
Why?
| | Asthma | 2 | 2017 | 1797 | 0.100 |
Why?
| | Cell Separation | 1 | 2014 | 306 | 0.100 |
Why?
| | Database Management Systems | 1 | 2013 | 51 | 0.100 |
Why?
| | Computer Graphics | 1 | 2013 | 41 | 0.100 |
Why?
| | Railroads | 1 | 2013 | 6 | 0.100 |
Why?
| | Cities | 1 | 2013 | 139 | 0.100 |
Why?
| | Treatment Outcome | 3 | 2020 | 11794 | 0.100 |
Why?
| | Lung Diseases, Interstitial | 1 | 2019 | 664 | 0.100 |
Why?
| | Cotinine | 1 | 2023 | 77 | 0.090 |
Why?
| | Prednisone | 1 | 2013 | 226 | 0.090 |
Why?
| | Carbon Dioxide | 1 | 2014 | 227 | 0.090 |
Why?
| | User-Computer Interface | 1 | 2013 | 165 | 0.090 |
Why?
| | Aerosols | 1 | 2013 | 146 | 0.090 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 232 | 0.090 |
Why?
| | DNA | 3 | 2014 | 1437 | 0.090 |
Why?
| | Body Fluids | 1 | 2012 | 71 | 0.090 |
Why?
| | Bacterial Translocation | 1 | 2012 | 52 | 0.090 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2011 | 16 | 0.080 |
Why?
| | Animals | 9 | 2018 | 38106 | 0.080 |
Why?
| | Cisplatin | 1 | 2013 | 345 | 0.080 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 5925 | 0.080 |
Why?
| | Base Sequence | 6 | 2013 | 2171 | 0.080 |
Why?
| | Flow Cytometry | 1 | 2014 | 1165 | 0.080 |
Why?
| | Staphylococcal Infections | 1 | 2015 | 393 | 0.080 |
Why?
| | Esophagus | 1 | 2012 | 262 | 0.080 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1368 | 0.080 |
Why?
| | Disease Models, Animal | 3 | 2018 | 4568 | 0.080 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 276 | 0.080 |
Why?
| | Mice | 4 | 2014 | 18358 | 0.080 |
Why?
| | Gastrointestinal Tract | 1 | 2012 | 204 | 0.070 |
Why?
| | Cloning, Molecular | 3 | 2010 | 538 | 0.070 |
Why?
| | RNA, Ribosomal | 4 | 2013 | 168 | 0.070 |
Why?
| | Robotics | 1 | 2010 | 90 | 0.070 |
Why?
| | Genetics, Microbial | 1 | 2008 | 10 | 0.070 |
Why?
| | Housing | 1 | 2009 | 142 | 0.070 |
Why?
| | Mice, Inbred C57BL | 3 | 2014 | 5995 | 0.070 |
Why?
| | Salinity | 1 | 2008 | 18 | 0.070 |
Why?
| | Double-Blind Method | 1 | 2013 | 2064 | 0.070 |
Why?
| | Software | 1 | 2013 | 680 | 0.070 |
Why?
| | Methane | 2 | 2020 | 45 | 0.070 |
Why?
| | Smoking | 1 | 2014 | 1477 | 0.060 |
Why?
| | Bacterial Load | 2 | 2021 | 67 | 0.060 |
Why?
| | Genetic Therapy | 1 | 2009 | 316 | 0.060 |
Why?
| | Genes, Archaeal | 2 | 2005 | 5 | 0.060 |
Why?
| | Ferrets | 2 | 2018 | 31 | 0.060 |
Why?
| | Macrophages | 1 | 2014 | 1507 | 0.060 |
Why?
| | Water | 3 | 2018 | 448 | 0.060 |
Why?
| | Intestinal Mucosa | 1 | 2012 | 675 | 0.060 |
Why?
| | Fresh Water | 1 | 2006 | 53 | 0.060 |
Why?
| | Selection, Genetic | 1 | 2008 | 263 | 0.060 |
Why?
| | RNA, Transfer | 2 | 2010 | 143 | 0.060 |
Why?
| | Sodium Chloride | 1 | 2006 | 138 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2010 | 2000 | 0.060 |
Why?
| | DNA Primers | 2 | 2008 | 505 | 0.050 |
Why?
| | Water Purification | 2 | 2017 | 156 | 0.050 |
Why?
| | Sequence Alignment | 2 | 2005 | 362 | 0.050 |
Why?
| | Disinfection | 2 | 2017 | 131 | 0.050 |
Why?
| | Genetic Variation | 3 | 2009 | 977 | 0.050 |
Why?
| | Gestational Age | 2 | 2017 | 990 | 0.050 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2017 | 196 | 0.050 |
Why?
| | Geography | 2 | 2014 | 187 | 0.050 |
Why?
| | Prokaryotic Initiation Factors | 1 | 2003 | 1 | 0.050 |
Why?
| | Eukaryotic Initiation Factors | 1 | 2003 | 12 | 0.050 |
Why?
| | Nasopharynx | 1 | 2023 | 72 | 0.050 |
Why?
| | Genes, Insect | 1 | 2003 | 22 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 532 | 0.050 |
Why?
| | Genes, Helminth | 1 | 2003 | 30 | 0.050 |
Why?
| | Genes, Fungal | 1 | 2003 | 55 | 0.050 |
Why?
| | Sequence Analysis, RNA | 2 | 2023 | 442 | 0.050 |
Why?
| | Archaeal Proteins | 1 | 2003 | 50 | 0.050 |
Why?
| | Databases, Protein | 1 | 2003 | 88 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2010 | 3418 | 0.050 |
Why?
| | Ribosomal Proteins | 1 | 2003 | 93 | 0.050 |
Why?
| | Fungal Proteins | 1 | 2003 | 143 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 2219 | 0.040 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 68 | 0.040 |
Why?
| | Ribosomes | 1 | 2003 | 193 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2017 | 4151 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2023 | 979 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2003 | 215 | 0.040 |
Why?
| | Quality of Life | 1 | 2013 | 3211 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2013 | 782 | 0.040 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 855 | 0.040 |
Why?
| | Oil and Gas Fields | 1 | 2020 | 32 | 0.040 |
Why?
| | Styrenes | 1 | 2020 | 3 | 0.040 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2003 | 207 | 0.040 |
Why?
| | Hospitals | 2 | 2015 | 733 | 0.040 |
Why?
| | Porphyrins | 1 | 2020 | 16 | 0.040 |
Why?
| | Colistin | 1 | 2020 | 10 | 0.040 |
Why?
| | Fluorobenzenes | 1 | 2020 | 17 | 0.040 |
Why?
| | Pyridinium Compounds | 1 | 2020 | 31 | 0.040 |
Why?
| | Protein Processing, Post-Translational | 1 | 2003 | 473 | 0.040 |
Why?
| | Plasmids | 1 | 2001 | 373 | 0.040 |
Why?
| | Methanobacterium | 1 | 1999 | 2 | 0.040 |
Why?
| | Neuroendocrine Cells | 1 | 2019 | 33 | 0.040 |
Why?
| | Bacillus | 1 | 1999 | 17 | 0.040 |
Why?
| | Colorado | 2 | 2020 | 4556 | 0.040 |
Why?
| | Hyperplasia | 1 | 2019 | 177 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2003 | 729 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2020 | 365 | 0.040 |
Why?
| | Fluorocarbons | 1 | 2020 | 120 | 0.030 |
Why?
| | RNA | 1 | 2005 | 912 | 0.030 |
Why?
| | Environmental Monitoring | 1 | 2020 | 347 | 0.030 |
Why?
| | Aged | 2 | 2017 | 26217 | 0.030 |
Why?
| | New Orleans | 1 | 2017 | 19 | 0.030 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2017 | 75 | 0.030 |
Why?
| | Chorioamnionitis | 1 | 2017 | 50 | 0.030 |
Why?
| | Infant, Extremely Premature | 1 | 2017 | 68 | 0.030 |
Why?
| | Equipment Contamination | 1 | 2017 | 67 | 0.030 |
Why?
| | Gram-Positive Bacteria | 1 | 1996 | 48 | 0.030 |
Why?
| | Betaproteobacteria | 1 | 2016 | 7 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Escherichia coli | 1 | 2001 | 835 | 0.030 |
Why?
| | Water Supply | 1 | 2017 | 89 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2003 | 1166 | 0.030 |
Why?
| | Ohio | 1 | 2016 | 146 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2020 | 2028 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1512 | 0.030 |
Why?
| | Pre-Eclampsia | 1 | 2017 | 206 | 0.030 |
Why?
| | Conserved Sequence | 2 | 2010 | 244 | 0.030 |
Why?
| | Mucociliary Clearance | 1 | 2015 | 44 | 0.030 |
Why?
| | Computational Biology | 2 | 2013 | 669 | 0.030 |
Why?
| | Pennsylvania | 1 | 2015 | 138 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 119 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 924 | 0.030 |
Why?
| | Pregnancy | 2 | 2017 | 7216 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 94 | 0.030 |
Why?
| | Larynx | 1 | 2014 | 56 | 0.030 |
Why?
| | Nanoparticles | 1 | 2020 | 517 | 0.020 |
Why?
| | Birth Weight | 1 | 2017 | 517 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2001 | 2805 | 0.020 |
Why?
| | Nitrates | 1 | 2013 | 96 | 0.020 |
Why?
| | New York City | 1 | 2013 | 85 | 0.020 |
Why?
| | Seasons | 1 | 2015 | 538 | 0.020 |
Why?
| | Genetic Markers | 1 | 2013 | 338 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 43 | 0.020 |
Why?
| | DNA, Viral | 1 | 2014 | 356 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2015 | 896 | 0.020 |
Why?
| | Lubiprostone | 1 | 2012 | 9 | 0.020 |
Why?
| | Alprostadil | 1 | 2012 | 29 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2015 | 507 | 0.020 |
Why?
| | Infant, Premature | 1 | 2017 | 620 | 0.020 |
Why?
| | Electrolytes | 1 | 2012 | 54 | 0.020 |
Why?
| | Hot Temperature | 1 | 2015 | 396 | 0.020 |
Why?
| | Chlorine | 1 | 2012 | 59 | 0.020 |
Why?
| | Cell Membrane Permeability | 1 | 2012 | 88 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 849 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 123 | 0.020 |
Why?
| | Suction | 1 | 2011 | 32 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2012 | 185 | 0.020 |
Why?
| | Chloride Channel Agonists | 1 | 2012 | 110 | 0.020 |
Why?
| | Random Allocation | 1 | 2012 | 365 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 6033 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 544 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2017 | 1135 | 0.020 |
Why?
| | Calcium Carbonate | 1 | 2010 | 14 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 525 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2013 | 373 | 0.020 |
Why?
| | Reference Values | 1 | 2012 | 798 | 0.020 |
Why?
| | Gene Transfer, Horizontal | 1 | 2010 | 34 | 0.020 |
Why?
| | Base Pairing | 1 | 2010 | 65 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 527 | 0.020 |
Why?
| | Mycobacterium avium | 1 | 2009 | 21 | 0.020 |
Why?
| | Endoscopy | 1 | 2012 | 317 | 0.020 |
Why?
| | Nucleotides | 1 | 2010 | 129 | 0.020 |
Why?
| | Administration, Oral | 1 | 2012 | 867 | 0.020 |
Why?
| | Pacific Ocean | 1 | 2008 | 8 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2015 | 835 | 0.020 |
Why?
| | Indoles | 1 | 2013 | 507 | 0.020 |
Why?
| | DNA, Archaeal | 1 | 2008 | 18 | 0.020 |
Why?
| | Biopsy | 1 | 2012 | 1082 | 0.020 |
Why?
| | Risk | 1 | 2011 | 923 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2008 | 157 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2010 | 501 | 0.020 |
Why?
| | Species Specificity | 1 | 2010 | 546 | 0.020 |
Why?
| | Morbidity | 1 | 2009 | 322 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 858 | 0.020 |
Why?
| | Body Mass Index | 1 | 2017 | 2447 | 0.020 |
Why?
| | Genetic Code | 1 | 2008 | 24 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 408 | 0.020 |
Why?
| | Cell Lineage | 1 | 2010 | 378 | 0.020 |
Why?
| | Genome | 1 | 2010 | 305 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1723 | 0.020 |
Why?
| | Temperature | 1 | 2010 | 633 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2192 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 2770 | 0.020 |
Why?
| | Cell Line | 1 | 2012 | 2823 | 0.020 |
Why?
| | Proteobacteria | 1 | 2006 | 16 | 0.020 |
Why?
| | Bacteroidetes | 1 | 2006 | 21 | 0.010 |
Why?
| | Chloroflexi | 1 | 2006 | 12 | 0.010 |
Why?
| | Acanthamoeba castellanii | 1 | 2005 | 1 | 0.010 |
Why?
| | Consensus Sequence | 1 | 2005 | 73 | 0.010 |
Why?
| | Giardia lamblia | 1 | 2005 | 23 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2006 | 328 | 0.010 |
Why?
| | Amino Acids | 1 | 2008 | 519 | 0.010 |
Why?
| | United States | 1 | 2022 | 16126 | 0.010 |
Why?
| | Databases, Genetic | 1 | 2005 | 238 | 0.010 |
Why?
| | Risk Factors | 1 | 2017 | 10919 | 0.010 |
Why?
| | Genomics | 1 | 2005 | 830 | 0.010 |
Why?
| | Signal Transduction | 1 | 2012 | 5226 | 0.010 |
Why?
| | Mycoplasma | 1 | 1996 | 5 | 0.010 |
Why?
| | Blotting, Southern | 1 | 1996 | 85 | 0.010 |
Why?
| | Bacillus subtilis | 1 | 1996 | 65 | 0.010 |
Why?
| | Kinetics | 1 | 1999 | 1568 | 0.010 |
Why?
| | Models, Molecular | 1 | 1999 | 1599 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2010 | 17330 | 0.010 |
Why?
|
|
Harris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|